Skip to main content
. Author manuscript; available in PMC: 2014 Jul 24.
Published in final edited form as: Cancer Res. 2007 Jul 1;67(13):6174–6182. doi: 10.1158/0008-5472.CAN-06-3455

Figure 5.

Figure 5

Depletion of BCAR3 from BT549 cells results in a loss of both BCAR3 and p130Cas from membrane ruffles. BT549 cells were treated with vehicle (H2O), control, or BCAR3-targeted siRNAs as described in Fig. 4. Forty-eight hours posttransfection, cells were replated onto fibronectin-coated coverslips in serum-containing medium, allowed to spread for 4 h, and processed for epifluorescence. BCAR3 and p130Cas were visualized as described in Materials and Methods, maintaining equal exposure lengths for each antibody. Merged images (C, F, and I). Arrowheads, sites of BCAR3-p130Cas colocalization at membrane ruffles. Arrows, sites of membrane ruffles devoid of BCAR3 and p130Cas in cells treated with BCAR3-targeted siRNA (G–I).